ZBTB33 and breast cancer: Despite the fact that the ZBTB33 mRNA abundance was reported as predictive of poor overall breast cancer survival in publicly available Metabric cohorts of 555 patients who underwent surgery for their primary breast cancer tumor, we are not able to easily compare this result to only TNBCs patients analyzed in our study [25].